Wegovy Average Weight Loss Results UK - From £124.99

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy UK Price - From £124.99

Get Wegovy at the cheapest UK price from £124.99 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy Average Weight Loss: Clinical Results & UK Patient Outcomes

Understanding wegovy average weight loss outcomes helps set realistic expectations before starting treatment. Clinical trials demonstrate that patients using Wegovy (semaglutide 2.4mg) achieve an average weight reduction of 15-20% of their initial body weight over 68 weeks, with UK patients reporting similar results when combined with lifestyle modifications [1]. At Cured Pharmacy, our UK-registered clinical team supports patients throughout their weight loss journey with transparent pricing from £124.99 and expert guidance from Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

What Is the Wegovy Average Weight Loss in Clinical Trials?

The wegovy average weight loss documented in the landmark STEP clinical trial programme provides robust evidence for its efficacy. In the STEP 1 trial involving 1,961 adults with obesity, participants using Wegovy 2.4mg weekly achieved an average weight loss of 14.9% of their initial body weight over 68 weeks, compared to 2.4% with placebo [1]. This translates to approximately 15.3kg (33.7 pounds) for someone starting at 105kg baseline weight.

UK patients typically experience comparable results when treatment is combined with a reduced-calorie diet and increased physical activity. The STEP trials showed that 86% of participants lost at least 5% of their body weight, whilst 69% achieved at least 10% reduction and 50% lost 15% or more [1]. These outcomes represent some of the most significant weight loss results achieved with any approved obesity medication, subject to individual response and adherence to the prescribed treatment protocol.

Wegovy Average Weight Loss Timeline: What to Expect Month by Month

The wegovy average weight loss timeline follows a gradual dose escalation schedule designed to minimise gastrointestinal side effects whilst optimising efficacy. During the first month at the 0.25mg starting dose, patients typically lose 2-4% of their body weight as their body adjusts to the medication [2]. Weight loss accelerates during months 2-4 as the dose increases through 0.5mg, 1mg, and 1.7mg strengths.

Maximum weight reduction occurs between weeks 60-68 at the maintenance dose of 2.4mg weekly. UK clinical data shows the most substantial wegovy average weight loss happens during months 5-12, with patients losing an additional 8-12% of their initial weight during this period [2]. Continued treatment beyond one year helps maintain these results, with the STEP 4 trial demonstrating that stopping Wegovy led to regaining two-thirds of lost weight, whilst those continuing treatment maintained their reduction [3].

Factors Influencing Individual Weight Loss Outcomes

Whilst clinical trials establish the wegovy average weight loss benchmark, individual results vary based on several factors. Starting BMI, adherence to dietary modifications, physical activity levels, metabolic health status, and concurrent medications all influence outcomes. Patients with higher baseline BMI often achieve greater absolute weight loss, though percentage reductions remain consistent across BMI categories [2]. Our UK prescribers at Cured Pharmacy assess these individual factors during your clinical consultation to provide personalised expectations and ongoing support throughout treatment.

Comparing Wegovy Average Weight Loss to Other Treatments

When evaluating wegovy average weight loss against alternative obesity medications, semaglutide 2.4mg demonstrates superior efficacy in head-to-head comparisons. The STEP 2 trial directly compared Wegovy to semaglutide 1mg (the diabetes formulation) in patients with type 2 diabetes, showing 9.6% weight loss with 2.4mg versus 7% with 1mg and 3.4% with placebo [4]. Compared to Saxenda (liraglutide 3mg), which produces average weight loss of 8-9%, Wegovy achieves approximately 60% greater reduction.

Recent data comparing wegovy average weight loss to Mounjaro (tirzepatide) shows tirzepatide may produce slightly higher reductions, with SURMOUNT-1 trial participants losing 15-22.5% depending on dose [5]. However, both medications represent significant advances over older treatments like Orlistat, which typically produces 3-5% weight loss. The choice between these GLP-1 and dual GLP-1/GIP agonists depends on individual tolerance, medical history, and prescriber assessment. All prescription weight loss medications available through Cured Pharmacy require clinical evaluation by our UK-registered prescribers to ensure appropriate selection and monitoring.

Treatment Type Frequency Starting Price
Wegovy Injection GLP-1 agonist Weekly from £89.00
Wegovy Oral Tablets GLP-1 agonist Daily from £83.00
Mounjaro GLP-1/GIP agonist Weekly from £145.00
Saxenda GLP-1 agonist Daily from £68.00
Orlistat Lipase inhibitor Three times daily from £32.00
Mysimba Combination therapy Twice daily from £125.95

Maximising Your Wegovy Average Weight Loss Results

Achieving optimal wegovy average weight loss outcomes requires more than medication alone—lifestyle modifications significantly enhance results. Clinical trials required participants to follow a 500-calorie daily deficit and engage in 150 minutes of weekly physical activity, factors that contributed substantially to the documented weight reductions [1]. UK patients who combine Wegovy with structured dietary changes and regular exercise consistently outperform those relying on medication alone.

Adherence to the dosing schedule proves critical for maximising wegovy average weight loss. Missing doses or prematurely discontinuing treatment compromises results, as demonstrated in the STEP 4 withdrawal trial [3]. Staying adequately hydrated, managing gastrointestinal side effects proactively, and maintaining regular follow-up with healthcare providers all support sustained weight reduction. Our clinical team at Cured Pharmacy provides ongoing support to help patients navigate challenges and optimise their treatment experience throughout the weight loss journey.

Realistic Expectations and Long-Term Maintenance

Setting realistic expectations around wegovy average weight loss helps patients remain motivated throughout treatment. Whilst clinical trials show impressive average reductions, individual responses range from minimal loss to exceeding 20% body weight reduction. Most patients begin noticing meaningful changes within 8-12 weeks, with continued improvement over the full 68-week trial period [2]. Weight loss typically plateaus after 60 weeks at the maintenance dose, at which point focus shifts to sustaining achieved reductions through continued medication and lifestyle adherence. Long-term data suggests Wegovy remains effective for weight maintenance when used continuously, though discontinuation commonly results in weight regain [3].

Understanding Wegovy Average Weight Loss in UK Clinical Practice

Real-world wegovy average weight loss data from UK clinical practice increasingly supports the outcomes observed in controlled trials. NHS pilot programmes and private clinic audits report average reductions of 12-16% over 12 months, slightly lower than trial results but still clinically significant [6]. This variance reflects real-world factors including variable adherence, less structured dietary support, and broader patient populations beyond strict trial inclusion criteria.

UK prescribing guidelines emphasise that wegovy average weight loss should be assessed at 16 weeks, with continuation recommended only if patients achieve at least 5% weight reduction at this checkpoint [6]. This evidence-based threshold ensures treatment continues for those responding appropriately whilst avoiding unnecessary expense and side effect exposure for non-responders. At Cured Pharmacy, our UK-registered prescribers follow MHRA-approved protocols and provide transparent pricing from £124.99 ensuring patients receive genuine licensed medication with proper clinical oversight throughout their treatment journey.

Safety Considerations and Wegovy Average Weight Loss Expectations

Whilst wegovy average weight loss results prove impressive, understanding potential side effects ensures informed treatment decisions. The most common adverse effects include nausea (44% of participants), diarrhoea (30%), vomiting (24%), and constipation (24%), typically mild-to-moderate and diminishing over time [1]. Serious side effects remain rare but include pancreatitis, gallbladder disease, and hypoglycaemia in patients taking concurrent diabetes medications.

The wegovy average weight loss achieved must be balanced against individual risk factors and contraindications. Wegovy is not suitable for patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or previous serious hypersensitivity to semaglutide [7]. Pregnancy and breastfeeding represent absolute contraindications. Our Superintendent Pharmacist Tarun Kumar (GPhC 2233073) and the UK clinical team at Cured Pharmacy conduct thorough assessments during the online consultation process to identify any safety concerns before prescribing. All patients require ongoing monitoring to ensure treatment remains appropriate and effective throughout the weight loss programme.

When to Seek Medical Advice During Wegovy Treatment

Patients should contact their healthcare provider if experiencing severe or persistent abdominal pain, signs of pancreatitis, symptoms of gallbladder disease, significant hypoglycaemia, or allergic reactions during Wegovy treatment. Whilst achieving wegovy average weight loss outcomes, monitoring for these rare but serious complications ensures prompt intervention if needed. The UK clinical team at Cured Pharmacy remains available via phone (+44) 116 4646009 to address concerns and provide guidance throughout your treatment journey, ensuring both safety and optimal therapeutic outcomes.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  3. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  4. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., ... & Garvey, W. T. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA, 325(14), 1403-1413. [accessed 15 August 2026]
  5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  6. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. [accessed 15 August 2026]
  7. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4mg solution for injection in pre-filled pen: Summary of Product Characteristics. [accessed 15 August 2026]
  8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How much weight can I realistically lose with Wegovy?
Clinical trials show wegovy average weight loss of 15-20% of initial body weight over 68 weeks, though individual results vary based on adherence to diet, exercise, and dosing schedule.
When will I start seeing wegovy average weight loss results?
Most patients notice initial weight reduction within 4-8 weeks, with the most significant wegovy average weight loss occurring between months 5-12 at the maintenance 2.4mg dose.
Is wegovy average weight loss maintained after stopping treatment?
Clinical data shows patients typically regain approximately two-thirds of lost weight within one year of discontinuing Wegovy, indicating ongoing treatment is necessary for weight maintenance.
How does Wegovy compare to Mounjaro for weight loss?
Wegovy average weight loss ranges 15-20% whilst Mounjaro achieves 15-22.5% depending on dose, making both highly effective options that require individual assessment by a UK prescriber.
Do I need a prescription for Wegovy in the UK?
Yes, Wegovy is a prescription-only medication requiring clinical assessment by a UK-registered prescriber, available through Cured Pharmacy's online consultation process.
What lifestyle changes improve Wegovy weight loss outcomes?
Combining Wegovy with a 500-calorie daily deficit and 150 minutes of weekly physical activity significantly enhances results beyond medication alone.
Are there any side effects that might affect weight loss progress?
Common gastrointestinal side effects like nausea and diarrhoea affect 30-44% of patients but typically diminish over time and rarely require treatment discontinuation.
How quickly is Wegovy delivered from Cured Pharmacy?
Following prescriber approval, Wegovy is dispatched in discreet packaging with next-day delivery options available across the UK from our GPhC-registered pharmacy (9012511).
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.